Bet Cell Therapy in Diabetes Type 1
This study is currently recruiting participants.
Verified December 2013 by Bart Keymeulen, AZ-VUB
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen Leuven
Information provided by (Responsible Party):
Bart Keymeulen, AZ-VUB
First received: May 2, 2011
Last updated: December 27, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||May 2018|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Jacobs-Tulleneers-Thevissen D, Chintinne M, Ling Z, Gillard P, Schoonjans L, Delvaux G, Strand BL, Gorus F, Keymeulen B, Pipeleers D; Beta Cell Therapy Consortium EU-FP7. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia. 2013 Jul;56(7):1605-14. doi: 10.1007/s00125-013-2906-0. Epub 2013 Apr 26.